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Aquaporin gene delivery to kidney. teral injection of adenovirus gave transient reporter gene
Background. Several aquaporin- (AQP) type water chan- expression in papillary and medullary tubular cells [7].
nels are expressed in kidney tubules and microvessels, includ- In a more recent study, delivery of the carbonic anhy-ing AQP1 in proximal tubule, thin descending limb of Henle
drase II (CAII) gene in CAII-deficient mice by retro-and vasa recta, AQP2 in collecting duct apical membrane, and
grade injection of a cationic liposome-CAII gene com-AQP3 and AQP4 in collecting duct basolateral membrane.
Mice deficient in these aquaporins have distinct phenotypic ab- plex gave expression in tubular cells of the outer medulla
normalities. AQP1 null mice are polyuria and unable to gener- and corticomedullary junction [11]. Gene and transcript
ate a concentrated urine after water deprivation. AQP2-T126M
expression were highest at day 3 after treatment andmutant mice and AQP3 null mice manifest nephrogenic diabe-
remained detectable at 1 month. The CAII-deficienttes insipidus (NDI) with severe polyuria, whereas AQP4 null
mice have only a mild defect in maximal urinary concentrat- mice showed improved urinary acidification after NH4Cl
ing ability. We reasoned that these mice could serve as useful administration at 3 weeks but not at 6 weeks after gene
models for gene replacement because of their predictable and delivery. To explore cardiac and renal protective effectsunambiguous phenotypes.
of kallikrein gene delivery in chronic renal failure, WolfMethods. In an initial feasibility study, an adenovirus direct-
et al. [12] delivered adenovirus carrying the human tissueing the expression of AQP1 was introduced into AQP1 null mice
by intravenous infusion. kallikrein cDNA into rats after 5/6 reduction of renal
Results. At 1 week after adenovirus infusion, AQP1 was seen mass. Kallikrein gene delivery significantly decreased
in many proximal tubules and microvessels. Compared with
total urinary protein and albumin excretion and in-untreated null mice, the treated mice were able to partially
creased levels of urinary kinin, nitrite/nitrate, and cGMP.concentrate their urine and lost less weight after water depriva-
tion. However, AQP1 transgene expression and functional cor- Kallikrein gene transfer reduced glomerular sclerotic le-
rection were lost over 3–5 weeks. sions, tubular damage, lumenal protein cast accumula-
Conclusion. Although there remain many technical prob- tion, and interstitial inflammation in the kidney, as welllems to overcome, aquaporin gene replacement has potential
as myocardial hypertrophy.applications in hereditary and acquired NDI, and in the tran-
Our laboratory recently generated a series of trans-sient modulation of renal fluid conservation.
genic mice deficient in the major renal water channels,
AQP1 through AQP4, as well as extrarenal water chan-
INTRODUCTION
nels. Based on the predictable and unambiguous renal
Gene delivery has been proposed to have potential abnormalities in these mice, we have begun to use these
applications in the therapy of hereditary and acquired mice as hosts to explore the feasibility of functional
diseases of the kidney including polycystic disease, neph- aquaporin gene delivery.
rogenic diabetes insipidus, and tumors [1–6]. Reporter
gene expression has been studied following viral and
PHENOTYPE OF TRANSGENIC AQUAPORINnon-viral gene delivery by renal artery, ureteral, and
KNOCKOUT MICEdirect intrarenal injection [7–10]. A single renal artery
injection of adenovirus produced transient expression of Distinct phenotype abnormalities in kidney and extra-
the-galactosidase reporter in proximal tubule epithelial renal organs have been identified in aquaporin null mice
cells [7]. A similar study using adenovirus and renal [13–15]. Deletion of AQP1 produced a severe defect in
artery delivery gave transient -galactosidase gene ex- urinary concentrating ability resulting in profound fluid
pression mainly in endothelial cells [6]. Retrograde ure- loss when mice were deprived of water [16]. Urine osmo-
lality remained in the range 600–700 mOsm even after
a 36-hour water deprivation and administration of theKey words: gene therapy, water transport, AQP1, urinary concentrat-
ing mechanism, transgenic mice, water permeability. vasopressin agonist DDAVP. Mechanistic analysis re-
vealed that the urinary concentrating defect results from 2002 by the International Society of Nephrology
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a combination of defective proximal tubule fluid absorp- toneal fluid transport [26] and dietary fat processing [27]
in AQP1 null mice, colonic water transport in AQP4tion [17], and defective countercurrent exchange because
of low water permeability in thin descending limb of null mice [28], and lung water permeability in AQP1
and AQP5 null mice [29]. However, the tissue-specificHenle [18] and outer medullary descending vasa recta
[19]. The decreased active fluid absorption in proximal expression of an aquaporin does not indicate physiologi-
cal significance as shown by the unimpaired gastric acidtubule after AQP1 deletion supports the general para-
digm that high epithelial cell water permeability is re- secretion [30] and skeletal muscle function [31] in AQP4
null mice.quired for active, near-isosmolar fluid transport. Mice
lacking AQP3, which is expressed mainly at the basolat-
eral membrane of cortical collecting duct principal cells,
AQP1 GENE DELIVERY TO KIDNEY
manifest nephrogenic diabetes insipidus with polyuria,
USING ADENOVIRUS
polydipsia, and urinary hypoosmolality [20]. The de-
Exploratory studies were done to assess the feasibilitycreased basolateral membrane water permeability im-
of aquaporin gene delivery in kidney. An adenoviruspairs the osmotic extraction of water from the collecting
(Ad5-type) encoding AQP1 was generated, purified, andduct lumen. Mice lacking AQP4, which is expressed
titered. Virus infection of CHO cell cultures gave strongmainly in inner medullary collecting duct, have a mildly
expression of functional AQP1 protein at the cell plasmaimpaired maximal urinary concentrating ability [21] de-
membrane [32]. Direct intrarenal injection of the adeno-spite 4-fold decreased transepithelial water permeability
virus gave strong AQP1 protein expression at one week[22]. In addition, double knockout mice lacking pairs
that was limited to the location of the injection site (Fig.of aquaporins (AQP1/AQP3, AQP1/AQP4, and AQP3/
1A). In preliminary experiments retrograde ureteral vi-AQP4) have been generated and characterized. Re-
rus infusion in rats gave strong AQP1 expression in ure-cently, a mouse knock-in model of human NDI was cre-
teral and renal papilla with lesser and patchy expressionated by targeted gene replacement in which the human
in more cortical regions of collecting duct. Attempts todisease-causing mutation T126M was introduced [23].
deliver AQP1 cDNA using liposomal vectors did notThe homozygous mutant mice express the AQP2-T126M
give transgene expression by retrograde ureteral andprotein but manifest severe polyuria and dehydration
intravenous approaches but was effective by intrarenalresulting in early neonatal death.
injection, but only at the injection site.Several interesting extrarenal phenotype abnormali-
Based on preliminary investigations, purified adenovi-ties have been documented in aquaporin null mice. Like
rus was administered to AQP1 null mice by tail veinthe proximal tubule, the salivary gland requires active
infusion. Some (10–20%) of the mice given adenovirustransepithelial fluid secretion to generate a near-isomo-
at the highest doses (1010 pfu) died within 30 min oflar primary saliva. Deletion of AQP5, the apical mem-
the infusion, possibly because of an immune responsebrane water channel in salivary gland acinar epithelia,
producing acute hypotension. The remaining mice sur-results in defective saliva production [24]. Whereas wild-
vived without little apparent morbidity. At 4 days aftertype mice produce large amounts of clear, non-viscous
adenovirus infusion, immunostaining and immunoblotsaliva following pilocarpine injection, AQP5 knockout
analysis showed strongest AQP1 protein expression inmice produce relatively little viscous fluid. The saliva
liver, followed by kidney and spleen. AQP1 protein waswas hyperosmolar and hypernatremic, suggesting that
expressed in hepatic sinusoids, apical and basolateralAQP5 null mice are able to pump salt actively into the
membranes in renal cortex (Fig. 1B), and medullary vasaacinar lumen, but that water permeability is too low to
recta (Fig. 1C). No AQP1 expression was found in glo-permit osmotic equilibration. In brain, the most strongly
meruli, limb of Henle, or collecting duct, and no AQP1expressed aquaporin is AQP4, which is found at the
was detected in untreated AQP1 null mice. This generalblood-brain and brain-cerebrospinal fluid (CSF) barriers
pattern of AQP1 protein expression in kidneys of adeno-in glial cells lining ependyma and pial surfaces in contact
virus-treated mice is consistent with reported studies ofwith the CSF. Based on this expression pattern, the hy-
adenovirus-reporter and other constructs. By tail-veinpothesis was tested that AQP4 plays a role in the produc-
infusion, Huard et al. [8] reported that a luciferase re-tion of brain edema in response to two established neuro-
porter was strongest in liver, followed by diaphragmaticlogical insults—acute water intoxication, producing
muscle and kidney, and Yayama et al. [33] found strong-serum hyponatremia and cellular brain edema, and isch-
est kallikrine gene expression in liver, followed by kid-emic stroke, producing brain swelling by a combination
ney. We note that the precise expression pattern of anof cellular and vasogenic edema [25]. AQP4 deletion
introduced gene depends not only on adenovirus doseconferred remarkable protection from brain edema in
and accessibility, but on the cell-specific kinetics of tran-these models, with improved mouse survival and clinical
script and protein synthesis and turnover.outcome, as well as reduced brain swelling. In other
recent studies, phenotype differences were found in peri- Functional correction of the urinary concentrating de-
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Fig. 1. Immunofluorescence localization of AQP1 protein in kidneys of adenovirus-treated AQP1 null mice. (A) AQP1 expression at four days
after direct intrarenal injection. *, injection site. (B) Localization of AQP1 in cortex, and (C ) medulla at four days after a single intravenous
infusion of adenovirus. Scale bar, 100 m.
Fig. 2. Urine osmolality and mouse weight loss in AQP1 null mice before vs. after virus infusion. (A) Urine osmolalities measured at indicated
times before and after a 36-hour water deprivation. Water deprivation tests were done prior to and after virus treatment. (B) Body weight loss
(expressed as percentage initial weight) in water deprivation tests done before and after virus treatment. * P  0.05. (C ) Increase in urine
osmolalities (mean  SE) for 36-hour water deprivation tests done at indicated times after virus treatment. Adapted from [32].
fect was evaluated in six AQP1 null mice given a single virus infusion, averaged urine osmolality after water dep-
intravenous infusion of AQP1-Ad5 (1010 pfu). A 36-hour rivation was 838  31 mOsm in the virus-treated AQP1
water deprivation test was done before and at three days null mice, significantly greater than that of 676  47
after virus infusion. Figure 2A shows little increase in mOsm in the untreated null mice but much less than that
urine osmolality in five out of six mice in the initial water in wild-type mice (Fig. 3A). The incomplete correction is
deprivation test, whereas urine osmolality increased sub- probably related to the lack of AQP1 expression in the
stantially in all mice in the second water deprivation test thin descending limb of Henle of the virus-treated mice,
done after the virus treatment. Figure 2B summarizes as well as to the patchy and low-level AQP1 expression
body weight loss after the first and second water depriva- in proximal tubule. In 11 mice urine osmolality increased
tion tests, showing significantly less weight loss after the to 900–1220 mOsm, but there was substantial mouse-to-
virus treatment. All of the untreated mice were judged
mouse variability, and 25% of the mice showed no
to be lethargic and hypoactive after water deprivation,
significant correction. Figure 3B summarizes the weightwhereas many of the treated mice were judged to have
loss in the same group of mice after a 36-hour waterminimal or no hypoactivity. Figure 2C shows that the
deprivation. Although all null mice lost substantiallyfunctional improvement in urinary osmolality after water
more weight than the wild-type mice, there was signifi-deprivation was lost over 3–5 weeks, as is generally found
cantly less weight loss in the virus-treated than the un-for first-generation adenoviral vectors like the Ad5 used
treated null mice. Water permeability in proximal tubulehere [7, 34–36]. Viral DNA (by PCR) and AQP1 tran-
apical membrane was significantly increased at one weekscript (by RT-PCR) were detectable by 17 weeks, through
in the virus-treated AQP1 null mice, but barely abovelevels were substantially reduced compared with 5 weeks
[32]. In a larger group of mice studied at five days after baseline by five weeks [32].
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PROSPECTS FOR AQUAPORIN
GENE THERAPY
The initial data using an adenoviral vector supports
the feasibility of aquaporin gene replacement in kidney.
High-level expression of aquaporins in cells is easily ac-
complished and is in general not associated with cellular
toxicity because aquaporins only facilitate passive water
transport driven by osmotic gradients. However, there
are substantial problems to overcome in the successful
implementation of aquaporin gene replacement in hu-
man disease, including gene delivery to targeted cell
types and persistent gene expression. Targeting collect-
ing duct epithelial cells in NDI by a retrograde ureteral
approach should be feasible, though the noninvasive ad-
ministration of a targeted construct is preferable. The
issue of persistent aquaporin gene expression will require
suitable vectors and improved understanding of tubular
cell turnover and renal stem cell biology. TransientFig. 3. Summary of (A) urine osmolalities and (B) weight loss in a
aquaporin expression in kidney tubules or microvesselsseries of wild-type, untreated AQP1 knockout, and virus-treated AQP1
knockout mice. Virus-treated knockout mice were given 5-10 109 pfu might have applications in modifying renal salt and water
adenovirus at three or four days prior to water deprivation test. Data handling. Finally, outside of the kidney, aquaporin gene(mean  SE) are shown for 36-hour water deprivation tests. Numbers
delivery may have applications in abnormalities of intra-of mice in each group are shown in parentheses. * P  0.05; ** P 
0.01 (Student t test). Adapted from [32]. cerebral and intraocular pressure regulation, defective
exocrine gladular secretions, and other processes where
regulation of fluid absorption/secretion or osmolality de-
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